Gambia vs Lithuania: Access to anti-retroviral drugs, female
Gambia
55.0%
in 2024
Lithuania
56.0%
in 2024
Gambia rank
111th
Lithuania rank
110th
Access to anti-retroviral drugs, female over time
- Gambia
- Lithuania
How they compare
Lithuania currently reports 56.0% against 55.0% in Gambia, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Lithuania ahead.
Gambia ranks 111th and Lithuania ranks 110th of 141 countries.
Across the 3 decades both report, Gambia averaged higher in 2 and Lithuania in 1.
Head to head by decade
| Decade | Gambia | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 2.3% | 0.7% | Lithuania |
| 2010s | 26.0% | 20.7% | 5.3% | Gambia |
| 2020s | 48.0% | 45.8% | 2.2% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Gambia or Lithuania?
- Lithuania, at 56.0% against 55.0% in Gambia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Gambia and Lithuania?
- 1.0%, with Lithuania ahead.
- How many years of comparable data are there for Gambia and Lithuania?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Lithuania rank globally for access to anti-retroviral drugs, female?
- Gambia ranks 111th and Lithuania ranks 110th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.